Literature DB >> 24415890

Two novel VPS33B mutations in a patient with arthrogryposis, renal dysfunction and cholestasis syndrome in mainland China.

Li-Ting Li1, Jing Zhao1, Rui Chen1, Jian-She Wang1.   

Abstract

Arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome is a rare genetic disorder and has not been described in China. We present a female infant with neonatal intrahepatic cholestasis from a Chinese family with ARC syndrome. All 23 coding exons and flanking introns of the VPS33B gene were amplified and sequenced using peripheral lymphocyte genomic DNA of the patient and her parents. Genetic testing revealed two novel mutations (c.1033delA and c.1567C>T) in the VPS33B gene. The patient is a compound heterozygote and her parents were heterozygous for each of the mutations.

Entities:  

Keywords:  Arthrogryposis, renal dysfunction and cholestasis syndrome; Cholestasis; Gene; Mutation; VPS33B

Mesh:

Substances:

Year:  2014        PMID: 24415890      PMCID: PMC3886028          DOI: 10.3748/wjg.v20.i1.326

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

Review 1.  ARC syndrome: an expanding range of phenotypes.

Authors:  K M Eastham; P J McKiernan; D V Milford; P Ramani; J Wyllie; W van't Hoff; S A Lynch; A A Morris
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

Review 2.  Liver histology in the arthrogryposis multiplex congenita, renal dysfunction, and cholestasis (ARC) syndrome: report of three new cases and review.

Authors:  S P Horslen; O W Quarrell; M S Tanner
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

3.  Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization.

Authors:  Andrew R Cullinane; Anna Straatman-Iwanowska; Andreas Zaucker; Yoshiyuki Wakabayashi; Christopher K Bruce; Guanmei Luo; Fatimah Rahman; Figen Gürakan; Eda Utine; Tanju B Ozkan; Jonas Denecke; Jurica Vukovic; Maja Di Rocco; Hanna Mandel; Hakan Cangul; Randolph P Matthews; Steve G Thomas; Joshua Z Rappoport; Irwin M Arias; Hartwig Wolburg; A S Knisely; Deirdre A Kelly; Ferenc Müller; Eamonn R Maher; Paul Gissen
Journal:  Nat Genet       Date:  2010-02-28       Impact factor: 38.330

4.  Cerebral defects and nephrogenic diabetes insipidus with the ARC syndrome: additional findings or a new syndrome (ARCC-NDI)?

Authors:  R A Coleman; J L Van Hove; C R Morris; J M Rhoads; M L Summar
Journal:  Am J Med Genet       Date:  1997-10-31

5.  Clinical characteristics and VPS33B mutations in patients with ARC syndrome.

Authors:  Joo Young Jang; Kyung Mo Kim; Gu-Hwan Kim; Eunsil Yu; Jin-Joo Lee; Young Seo Park; Han-Wook Yoo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-03       Impact factor: 2.839

6.  Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome.

Authors:  Paul Gissen; Colin A Johnson; Neil V Morgan; Janneke M Stapelbroek; Tim Forshew; Wendy N Cooper; Patrick J McKiernan; Leo W J Klomp; Andrew A M Morris; James E Wraith; Patricia McClean; Sally A Lynch; Richard J Thompson; Bryan Lo; Oliver W Quarrell; Maja Di Rocco; Richard C Trembath; Hanna Mandel; S Wali; Fiona E Karet; A S Knisely; Roderick H J Houwen; Deirdre A Kelly; Eamonn R Maher
Journal:  Nat Genet       Date:  2004-03-28       Impact factor: 38.330

Review 7.  Arthrogryposis, renal dysfunction and cholestasis syndrome: report of five patients from three Italian families.

Authors:  M Di Rocco; F Callea; B Pollice; M Faraci; F Campiani; C Borrone
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

8.  Clinical and molecular genetic features of ARC syndrome.

Authors:  Paul Gissen; Louise Tee; Colin A Johnson; Emmanuelle Genin; Almuth Caliebe; David Chitayat; Carol Clericuzio; Jonas Denecke; Maja Di Rocco; Björn Fischler; David FitzPatrick; Angeles García-Cazorla; Delphine Guyot; Sebastien Jacquemont; Sibylle Koletzko; Bruno Leheup; Hanna Mandel; Maria Teresa Vieira Sanseverino; Roderick H J Houwen; Patrick J McKiernan; Deirdre A Kelly; Eamonn R Maher
Journal:  Hum Genet       Date:  2006-08-01       Impact factor: 4.132

  8 in total
  2 in total

1.  One case of arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome featuring an incomplete and mild phenotype.

Authors:  Lianhu Yu; Dan Li; Ting Zhang; Yongmei Xiao; Yizhong Wang; Ting Ge
Journal:  BMC Nephrol       Date:  2022-06-27       Impact factor: 2.585

Review 2.  Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome: from molecular genetics to clinical features.

Authors:  Yaoyao Zhou; Junfeng Zhang
Journal:  Ital J Pediatr       Date:  2014-09-20       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.